Arcus Biosciences Inc.

NYSE: RCUS · Real-Time Price · USD
10.37
0.46 (4.64%)
At close: Aug 15, 2025, 3:59 PM
10.64
2.60%
After-hours: Aug 15, 2025, 07:29 PM EDT

Arcus Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-298M -391M -283M -270M -249M -231M -307M -293.46M -287.38M -279.01M -267M 79.82M 66.77M 57.43M 52.83M -278.39M -198.59M -167.7M
Depreciation & Amortization
10M 10M 10M 10M 9M 9M 8M 6.48M 7.04M 6.54M 6M 4.08M 4.07M 3.96M 3.84M 6.1M 5.3M 4.69M
Stock-Based Compensation
67M 72M 76M 77M 76M 74M 73M 71.52M 69.52M 66.52M 64.06M 61.36M 59.94M 58.31M 54.53M 48.6M 40.02M 31.12M
Other Working Capital
21M -50M -47M -32M -109M -64M -70M -82.54M -80.26M -122.32M 615M 275.61M 313.87M 334.53M -370.85M -20.16M 163.69M 164.21M
Other Non-Cash Items
-151M 49M 53M 36M 22M 7M 4M 24.25M -1.78M 3.46M 11M 16.19M 16.62M 14.28M 8.25M 3.09M 1.69M 708K
Deferred Income Tax
n/a n/a n/a 16M -13M n/a n/a -16M 13M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
33M -23M -23M -24M -89M -83M -84M -80.53M -106.36M -112.46M 623M 283.25M 324.77M 330.17M -375.62M -23.36M 177.66M 207.31M
Operating Cash Flow
-339M -300M -170M -158M -247M -210M -306M -287.74M -305.7M -314M 438M 445.64M 472.84M 464.15M -256.17M -243.95M 26.07M 76.13M
Capital Expenditures
-3M -3M -6M -11M -20M -25M -24M -18.88M -10.2M -12.21M -12M -19.63M -26.17M -25.23M -26.08M -19.09M -12.3M -6.49M
Cash Acquisitions
n/a n/a n/a 21M n/a -31M -163M -184M -163M -126.5M 5.5M 5.5M 5.5M n/a n/a n/a n/a n/a
Purchase of Investments
-964M -1.01B -1.04B -986M -988M -1.02B -788M -828.61M -870.87M -1.02B -1.24B -1.22B -1.11B -904.04M -718.87M -755.61M -970.66M -923.17M
Sales Maturities Of Investments
1.16B 1.13B 965M 890M 941M 942M 1.01B 1.06B 1.1B 1.01B 837M 795.39M 584.52M 594.51M 741.08M 751.68M 661.44M 518.06M
Other Investing Acitivies
n/a 63M -102M -123M -102M -134M 163M 184.25M 166M 129.5M -267.5M -240.54M -324.04M -309.47M 22M -3.92M -309.22M -405.11M
Investing Cash Flow
191M 117M -84M -107M -67M -104M 194M 212.81M 225.26M -15.94M -413M -440.9M -552.95M -334.75M -3.87M -23.01M -321.52M -411.6M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
1M n/a n/a n/a -1M n/a n/a n/a n/a n/a n/a 220.24M 220.24M 220.24M 220.24M -11K -27K -21K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
98M 48M 49M 54M 7M 8M 8M 16.2M 18.2M 19.2M 33.2M 33.67M 31.99M 30.23M 17.11M 7.12M 6.07M 6.2M
Financial Cash Flow
240M 190M 277M 282M 240M 261M 33M 41M 38M 19M 33M 33.67M 31.99M 30.22M 237.34M 227.35M 333.55M 660.18M
Net Cash Flow
92M 7M 23M 17M -74M -53M -79M -33.65M -42.63M -310.79M 58.08M 38.22M -47.85M 159.54M -22.7M -39.62M 38.1M 324.72M
Free Cash Flow
-342M -303M -176M -169M -267M -235M -330M -306.62M -315.9M -326.21M 426M 426.01M 446.67M 438.92M -282.25M -263.04M 13.77M 69.64M